Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Alexandrakis

Showing results (101-110 of 141) with videos related to

Pageof 15
Sort By:
Transfusion Medicine (Oxford, England)|April 16, 2003
Quick detection of Leishmania in peripheral blood by flow cytometry. Is prestorage leucodepletion necessary for leishmaniasis prevention in endemic areas?D S Kyriakou, M G Alexandrakis, F H Passam, et al.
Clinical Chemistry and Laboratory Medicine|November 24, 2004
Bone marrow microvascular density and angiogenic growth factors in multiple myelomaMichael G Alexandrakis, Freda J Passam, Emmanuel Ganotakis, et al.
European Journal of Histochemistry : EJH|April 13, 2005
The assessment of proliferating cell nuclear antigen immunostaining in myelodysplastic syndromes and its prognostic significanceM G Alexandrakis, F H Passam, K Dambaki, et al.
Medical Oncology (Northwood, London, England)|March 10, 2012
Serum concentrations and clinical significance of soluble CD40 ligand in patients with multiple myelomaG Tsirakis, C A Pappa, F E Psarakis, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 8, 2004
Clinical significance of circulating endothelial adhesion molecules (sE-selectin and sICAM) in untreated multiple myeloma patientsMichael G Alexandrakis, Freda H Passam, Katerina Sfiridaki, et al.
Clinical Chemistry and Laboratory Medicine|September 24, 2005
Systemic levels of interleukin-6 and matrix metalloproteinase-9 in patients with multiple myeloma may be useful as prognostic indexes of bone diseaseAikaterini Sfiridaki, Spiros Miyakis, George Tsirakis, et al.
Leukemia Research|November 5, 2013
Positive correlation between bone marrow mast cell density and ISS prognostic index in patients with multiple myelomaConstantina A Pappa, George Tsirakis, Parascevi Roussou, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 1, 2015
High density of tryptase-positive mast cells in patients with multiple myeloma: correlation with parameters of disease activityMaria Devetzoglou, Rodanthi Vyzoukaki, Maria Kokonozaki, et al.
American Journal of Hematology|February 3, 2004
Serum level of interleukin-16 in multiple myeloma patients and its relationship to disease activityMichael G Alexandrakis, Freda H Passam, Despina S Kyriakou, et al.
Medical Oncology (Northwood, London, England)|November 27, 2013
Increased serum levels of MIP-1alpha correlate with bone disease and angiogenic cytokines in patients with multiple myelomaGeorge Tsirakis, Parascevi Roussou, Constantina A Pappa, et al.
Pageof 15

Showing results (101-110 of 141) with videos related to

Sort By:
Pageof 15
Transfusion Medicine (Oxford, England)|April 16, 2003
Quick detection of Leishmania in peripheral blood by flow cytometry. Is prestorage leucodepletion necessary for leishmaniasis prevention in endemic areas?D S Kyriakou, M G Alexandrakis, F H Passam, et al.
Clinical Chemistry and Laboratory Medicine|November 24, 2004
Bone marrow microvascular density and angiogenic growth factors in multiple myelomaMichael G Alexandrakis, Freda J Passam, Emmanuel Ganotakis, et al.
European Journal of Histochemistry : EJH|April 13, 2005
The assessment of proliferating cell nuclear antigen immunostaining in myelodysplastic syndromes and its prognostic significanceM G Alexandrakis, F H Passam, K Dambaki, et al.
Medical Oncology (Northwood, London, England)|March 10, 2012
Serum concentrations and clinical significance of soluble CD40 ligand in patients with multiple myelomaG Tsirakis, C A Pappa, F E Psarakis, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 8, 2004
Clinical significance of circulating endothelial adhesion molecules (sE-selectin and sICAM) in untreated multiple myeloma patientsMichael G Alexandrakis, Freda H Passam, Katerina Sfiridaki, et al.
Clinical Chemistry and Laboratory Medicine|September 24, 2005
Systemic levels of interleukin-6 and matrix metalloproteinase-9 in patients with multiple myeloma may be useful as prognostic indexes of bone diseaseAikaterini Sfiridaki, Spiros Miyakis, George Tsirakis, et al.
Leukemia Research|November 5, 2013
Positive correlation between bone marrow mast cell density and ISS prognostic index in patients with multiple myelomaConstantina A Pappa, George Tsirakis, Parascevi Roussou, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 1, 2015
High density of tryptase-positive mast cells in patients with multiple myeloma: correlation with parameters of disease activityMaria Devetzoglou, Rodanthi Vyzoukaki, Maria Kokonozaki, et al.
American Journal of Hematology|February 3, 2004
Serum level of interleukin-16 in multiple myeloma patients and its relationship to disease activityMichael G Alexandrakis, Freda H Passam, Despina S Kyriakou, et al.
Medical Oncology (Northwood, London, England)|November 27, 2013
Increased serum levels of MIP-1alpha correlate with bone disease and angiogenic cytokines in patients with multiple myelomaGeorge Tsirakis, Parascevi Roussou, Constantina A Pappa, et al.
Pageof 15